2024-20896. Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect or Measure Nucleic Acid From Viruses Associated With Head and Neck Cancers  

  • Table 1—Device To Detect or Measure Nucleic Acid From Viruses Associated With Head and Neck Cancers Risks and Mitigation Measures

    Identified risks to health Mitigation measures
    False test results Use of certain specimen collection and transport devices; Certain labeling information; and Certain design verification and validation.
    Failure to correctly interpret the test results Certain labeling information.

Document Information

Effective Date:
9/16/2024
Published:
09/16/2024
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final amendment; final order.
Document Number:
2024-20896
Dates:
This order is effective September 16, 2024. The classification was applicable on May 11, 2020.
Pages:
75491-75493 (3 pages)
Docket Numbers:
Docket No. FDA-2024-N-4061
Topics:
Biologics, Laboratories, Medical devices
PDF File:
2024-20896.pdf
CFR: (1)
21 CFR 866